QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
JCA learnings: Sharing expertise across the athagoras Group
Our Market Access Strategy unit recently held a workshop focused on Joint Clinical Assessment (JCA) learnings.
The session brought together perspectives from Quantify Research and our sister companies within the athagoras Group creating a valuable opportunity to learn from practical experience in JCA dossier preparation and strategy.
Together, we explored:
📌key considerations in preparing a JCA dossier
📌 how evidence planning connects to access strategy
📌 learnings from […]
New starter | From internship to Research Analyst
We are pleased to welcome Pankaj Khajuria as a Research Analyst in our Evidence, Review and Synthesis unit Quantify Research India.
Pankaj first joined Quantify Research as an ERS Intern where he contributed to systematic literature reviews, evidence synthesis, and HEOR projects.
He brings a strong academic foundation in pharmacology, toxicology, and biomedical research.
Pankaj completed his Bachelor of Pharmacy, followed by an M.Pharm. in Pharmacology at the University Institute of Pharmaceutical […]
A week of connection across the athagoras group
A good week in evidence, access, and collaboration.
Last Monday, 22 June, we had the pleasure of hosting Giuseppe Pileggi, CEO of athagoras, for the athagoras Townhall in Stockholm.
It was a valuable opportunity to connect as a group, share perspectives, and discuss how we continue building specialist European capabilities across RWE, HEOR, market access, and regulatory affairs.
We also warmly welcome […]
TLV update: What actually changes as of 1 October for market access in Sweden
TLV has published new general guidelines and version 7.0 of its handbook for pharmaceutical reimbursement and pricing applications. TLV’s new general guidelines and application regulations apply from 1 October 2026. For market access teams, this is not a methodological reset. TLV is mainly consolidating existing assessment practice into one framework. Comparator choice, severity assessment and health economic evaluation are described more explicitly but largely reflect current practice.
The practical changes […]
